Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS - A Novel Therapeutic Opportunity.

Research output: Contribution to journalArticle

Standard

Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS - A Novel Therapeutic Opportunity. / Winstedt, Lena; Järnum, Sofia; Nordahl, Emma Andersson; Olsson, Andreas; Runström, Anna; Bockermann, Robert; Karlsson, Christofer; Malmström, Johan; Samuelsson Palmgren, Gabriella; Malmqvist, Ulf; Björck, Lars; Kjellman, Christian.

In: PLoS ONE, Vol. 10, No. 7, e0132011, 2015.

Research output: Contribution to journalArticle

Harvard

APA

CBE

MLA

Vancouver

Author

Winstedt, Lena ; Järnum, Sofia ; Nordahl, Emma Andersson ; Olsson, Andreas ; Runström, Anna ; Bockermann, Robert ; Karlsson, Christofer ; Malmström, Johan ; Samuelsson Palmgren, Gabriella ; Malmqvist, Ulf ; Björck, Lars ; Kjellman, Christian. / Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS - A Novel Therapeutic Opportunity. In: PLoS ONE. 2015 ; Vol. 10, No. 7.

RIS

TY - JOUR

T1 - Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS - A Novel Therapeutic Opportunity.

AU - Winstedt, Lena

AU - Järnum, Sofia

AU - Nordahl, Emma Andersson

AU - Olsson, Andreas

AU - Runström, Anna

AU - Bockermann, Robert

AU - Karlsson, Christofer

AU - Malmström, Johan

AU - Samuelsson Palmgren, Gabriella

AU - Malmqvist, Ulf

AU - Björck, Lars

AU - Kjellman, Christian

PY - 2015

Y1 - 2015

N2 - ClinicalTrials.gov NCT01802697.

AB - ClinicalTrials.gov NCT01802697.

U2 - 10.1371/journal.pone.0132011

DO - 10.1371/journal.pone.0132011

M3 - Article

VL - 10

JO - PLoS ONE

T2 - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 7

M1 - e0132011

ER -